Demaria’s team then showed that combination of radiotherapy and anti-CTLA4 blockade in NSCLC patients that have failed anti-CTLA4 alone or in combination with chemotherapy, induced IFN-β in the blood and an antitumor T cell response in responding patients (64). The gene discussed is IFNB1; the disease is non-small cell lung carcinoma.